Search research articles
Contact Us
Filters
Showing results (151-160 of 186) with videos related to
Page
of 19
Sort By:
Microbiological Research
|
October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension
Jiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
Scientific Reports
|
April 29, 2016
MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells
Yan Zeng, Xiaoying Zhang, Kang Kang, et al.
Pulmonary Circulation
|
July 22, 2024
Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease
Wenjun He, Chunli Liu, Xuanyi Li, et al.
Nature Communications
|
June 10, 2022
A single-cell transcriptomic atlas characterizes the silk-producing organ in the silkworm
Yan Ma, Wenhui Zeng, Yongbing Ba, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2019
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition
Junyi Huang, Wenju Lu, Haiping Ouyang, et al.
The New Phytologist
|
October 9, 2025
Domestication-medicated erect growth confines soybean basal branching by upregulating GmBRC1a and GmBRC1b
Hongtao Ji, Ruizhen Tang, Yanyan Cha, et al.
Frontiers in Pharmacology
|
May 17, 2018
Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
Ruijuan Guan, Jian Wang, Ziying Li, et al.
British Journal of Pharmacology
|
March 4, 2023
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats
Chenting Zhang, Tingting Zhang, Yue Xing, et al.
British Journal of Pharmacology
|
October 2, 2021
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist
Qiuyu Zheng, Wenju Lu, Han Yan, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine
|
January 19, 2026
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Yanan Zhou, Gaoying Chen, Xiang Li, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 186) with videos related to
Sort By:
Page
of 19
Microbiological Research
|
October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension
Jiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
Scientific Reports
|
April 29, 2016
MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells
Yan Zeng, Xiaoying Zhang, Kang Kang, et al.
Pulmonary Circulation
|
July 22, 2024
Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease
Wenjun He, Chunli Liu, Xuanyi Li, et al.
Nature Communications
|
June 10, 2022
A single-cell transcriptomic atlas characterizes the silk-producing organ in the silkworm
Yan Ma, Wenhui Zeng, Yongbing Ba, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2019
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition
Junyi Huang, Wenju Lu, Haiping Ouyang, et al.
The New Phytologist
|
October 9, 2025
Domestication-medicated erect growth confines soybean basal branching by upregulating GmBRC1a and GmBRC1b
Hongtao Ji, Ruizhen Tang, Yanyan Cha, et al.
Frontiers in Pharmacology
|
May 17, 2018
Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
Ruijuan Guan, Jian Wang, Ziying Li, et al.
British Journal of Pharmacology
|
March 4, 2023
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats
Chenting Zhang, Tingting Zhang, Yue Xing, et al.
British Journal of Pharmacology
|
October 2, 2021
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist
Qiuyu Zheng, Wenju Lu, Han Yan, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine
|
January 19, 2026
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Yanan Zhou, Gaoying Chen, Xiang Li, et al.
Page
of 19